Coverage is better for the diabetes indication, which is why off-label Ozempic or Mounjaro for weight loss remains common where a patient has prediabetes, comorbid metabolic syndrome, or struggles to manage belly fat
Unlike oral supplements, which must pass through the digestive system, these injections offer immediate bioavailability
Retatrutide showing promise in obesity (and type 2 diabetes)
It also has secondary applications related to cardiovascular and kidney health for eligible patients
The Weight Loss + Labs plan is $668 per vial and includes a provider call, two in-home nurse visits, 7 to 10 semaglutide injections, and a blood draw with lab work
Motion's adaptive goals adjust to your actual activity level rather than holding you to a fixed target